<DOC>
	<DOCNO>NCT01181479</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety low dose transdermal contraceptive delivery system contain ethinyl estradiol levonorgestrel .</brief_summary>
	<brief_title>Study Evaluate Contraceptive Efficacy/Safety Low Dose EE/LNG Transdermal Contraceptive Delivery System</brief_title>
	<detailed_description>Comparative evaluation AG200-15 versus OC regard safety , contraceptive efficacy , cycle control ( bleed pattern ) , subject compliance serum concentration EE LNG . To evaluate TCDS wearability ( include adhesion ) .</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy female 17 ( state legal age consent receive contraceptive 17 ) 40 year Regular , consistent menstrual cycle 25 35 day Sexually active woman request birth control In good general health , confirm medical history , physical ( include gynecologic ) examination screen laboratory value Known suspected pregnancy ; Lactating woman Significant skin reaction transdermal preparation sensitivity surgical / medical tape Any disease may worsen hormonal treatment ( cardiovascular , liver , metabolic ) Use contraceptive method study medication</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Contraceptive</keyword>
</DOC>